Autophagy inhibition and ferroptosis activation during atherosclerosis: Hypoxia-inducible factor 1α inhibitor PX-478 alleviates atherosclerosis by inducing autophagy and suppressing ferroptosis in macrophages - 28/03/23
, Zihui Yuan a, b , Jian Wang a, b, ⁎ Abstract |
Objective |
To elucidate the key regulator responsible for autophagy and ferroptosis, and if specific pharmacological inhibitor of upregulated gene exerted the pro-autophagic and anti-ferroptotic effect on macrophage to alleviate the atherosclerosis.
Methods |
Autophagy and ferroptosis were evaluated in atherosclerotic lesions and THP-1 macrophages exposed to ox-LDL. Autophagy/ferroptosis-related differentially expressed genes (DEGs) in atherosclerosis were identified by bioinformatic analysis of GSE97210 dataset, and were validated in atherosclerotic cells and tissues. The efficacy and mechanism of pharmacological inhibition of the validated DEGs on alleviating atherosclerosis were explored in vivo and in vitro.
Results |
Atherosclerotic lesions were characterized by autophagy inhibition and ferroptosis activation in macrophages. The crosslink between autophagy and ferroptosis were demonstrated. Ox-LDL induced THP-1 macrophage foam cell formation, autophagy dysfunction, and ferroptosis occurrence. Rapamycin ameliorated and, conversely, erastin deteriorated the effect of ox-LDL on THP-1 macrophages. Eleven autophagy/ferroptosis-related DEGs were identified in atherosclerosis vs. normal. The up-regulated expression of HIF-1α was verified in atherosclerotic lesions and THP-1 macrophages induced by ox-LDL. HIF-1α inhibitor PX-478 restored autophagy function, depressed ferroptosis, and reduced lipid accumulation in ox-LDL induced THP-1 macrophage. Autophagy inhibitor 3-MA obviously abrogated the pro-autophagic, anti-ferroptotic, and anti-atherosclerotic effects of PX-478. PX-478 treatment down-regulated HIF-1α expression and reduced atherosclerotic plaques in the mice model.
Conclusions |
Autophagy is inhibited, ferroptosis is activated, and crosslink occurs between autophagy and ferroptosis during atherosclerosis. HIF-1α, an upregulated DEG between atherosclerosis and normal, co-regulates autophagy and ferroptosis. HIF-1α inhibitor PX-478 attenuates foam cell formation and lessens atherosclerosis by enhancing autophagy and depressing ferroptosis in macrophages.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Autophagy was depressed and ferroptosis was activated during the atherosclerosis. |
• | HIF-1α was an autophagy and ferroptosis-related DEG thought bioinformatic analysis. |
• | HIF-1α was upregulated in macrophage foam cells and tissue atherosclerotic lesions. |
• | PX-478 reduced macrophage lipid accumulation by affecting autophagy and ferroptosis. |
• | PX-478, a HIF-1α inhibitor, alleviated atherosclerosis in high fat diet-fed mice. |
Abbreviations : LE, CA, AS, DM, GPX4, LC3, DAPI, Ox-LDL, GSH, HFD, ND, DEGs, BID, HIF-1α., LAMP2, TP63, RB1, BNIP3, ATG7, EGFR, GABARAPL2, RELA, SQSTM1, HIF-1α, ROS, 3-MA
Keywords : Autophagy, Ferroptosis, Atherosclerosis, Macrophages, HIF-1α, PX-478
Plan
Vol 161
Article 114333- mai 2023 Retour au numéro
Article précédent
- PINK1/Parkin pathway-mediated mitophagy by AS-IV to explore the molecular mechanism of muscle cell damage
- Lanqi Li, Tingjuan Huang, Jie Yang, Peidan Yang, Haixia Lan, Jian Liang, Donghong Cai, Huiya Zhong, Wei Jiao, Yafang Song
- Novel gold(I) complexes induce apoptosis in leukemia cells via the ROS-induced mitochondrial pathway with an upregulation of Harakiri and overcome multi drug resistances in leukemia and lymphoma cells and sensitize drug resistant tumor cells to apoptosis in vitro
- Marie-C. Ahrweiler-Sawaryn, Animesh Biswas, Corazon Frias, Jerico Frias, Nicola L. Wilke, Nathalie Wilke, Albrecht Berkessel, Aram Prokop
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?